| scientific journal | Q5633421 |
| academic journal | Q737498 |
| open-access journal | Q773668 |
| P6981 | ACNP journal ID | 3172592 |
| P8375 | Crossref journal ID | 104327 |
| P5115 | Directory of Open Access Journals ID | 2090-3111 |
| 2090-312X | ||
| P1058 | ERA Journal ID | 201410 |
| P236 | ISSN | 2090-3111 |
| 2090-312X | ||
| P7363 | ISSN-L | 2090-312X |
| P4730 | Mir@bel journal ID | 14534 |
| P1055 | NLM Unique ID | 101567074 |
| P856 | official website | https://www.hindawi.com/journals/pc/ |
| P10283 | OpenAlex ID | V70845872 |
| P3181 | OpenCitations bibliographic resource ID | 209663 |
| P8104 | Paperity journal ID | 144850 |
| P12834 | PMC journal ID | 1634 |
| P7662 | Scilit journal ID | 320604 |
| P1156 | Scopus source ID | 21100470767 |
| P166 | award received | DOAJ seal | Q73548471 |
| P972 | catalog | Directory of Open Access Journals | Q1227538 |
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P17 | country | United Kingdom | Q145 |
| P495 | country of origin | United Kingdom | Q145 |
| P8875 | indexed in bibliographic review | Emerging Sources Citation Index | Q22908122 |
| Scopus | Q371467 | ||
| P407 | language of work or name | English | Q1860 |
| P138 | named after | prostate cancer | Q181257 |
| P123 | publisher | Hindawi Publishing Corporation | Q1619253 |
| P1476 | title | Prostate cancer |
| Q42836179 | 3D versus 2D Systematic Transrectal Ultrasound-Guided Prostate Biopsy: Higher Cancer Detection Rate in Clinical Practice |
| Q104681011 | A Multicentric, Retrospective Efficacy and Safety Study of Nanosomal Docetaxel Lipid Suspension in Metastatic Castration-Resistant Prostate Cancer |
| Q43103417 | A Pilot Study of Laparoscopic Doppler Ultrasound Probe to Map Arterial Vascular Flow within the Neurovascular Bundle during Robot-Assisted Radical Prostatectomy |
| Q39111459 | A comparison of radical perineal, radical retropubic, and robot-assisted laparoscopic prostatectomies in a single surgeon series |
| Q35505629 | A retrospective study on pathologic features and racial disparities in prostate cancer |
| Q91477358 | Achieving PSA < 0.2 ng/ml before Radiation Therapy Is a Strong Predictor of Treatment Success in Patients with High-Risk Locally Advanced Prostate Cancer |
| Q30276119 | Advances in Radiotherapy for Prostate Cancer Treatment |
| Q38170367 | Advances in Robotic-Assisted Radical Prostatectomy over Time |
| Q38730585 | An NTCP Analysis of Urethral Complications from Low Doserate Mono- and Bi-Radionuclide Brachytherapy. |
| Q35549863 | An update on the changing indications for androgen deprivation therapy for prostate cancer |
| Q37597723 | Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes. |
| Q35996120 | Analysis of Prostate Cancer Susceptibility Variants in South African Men: Replicating Associations on Chromosomes 8q24 and 10q11. |
| Q41206632 | Analysis of preoperative detection for apex prostate cancer by transrectal biopsy |
| Q41884768 | Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men |
| Q36530136 | Androgen deprivation therapy toxicity and management for men receiving radiation therapy |
| Q42261015 | Androgen receptor-target genes in african american prostate cancer disparities |
| Q92888919 | Anesthesia for Open Radical Retropubic Prostatectomy: A Comparison between Combined Spinal Epidural Anesthesia and Combined General Epidural Anesthesia |
| Q36946259 | Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy. |
| Q89849258 | Association of Angiotensin I Converting Enzyme Insertion/287 bp Deletion Polymorphisms and Proliferative Prostatic Diseases among Lebanese Men |
| Q42247367 | Atypical Small Acinar Proliferation: Repeat Biopsy and Detection of High Grade Prostate Cancer |
| Q35433194 | Bevacizumab and weekly docetaxel in patients with metastatic castrate-resistant prostate cancer previously exposed to docetaxel |
| Q35550202 | Beyond diagnosis: evolving prostate biopsy in the era of focal therapy |
| Q37607461 | Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus |
| Q39714298 | Blood level omega-3 Fatty acids as risk determinant molecular biomarker for prostate cancer |
| Q37166534 | Bone-targeted therapies in metastatic castration-resistant prostate cancer: evolving paradigms. |
| Q38626224 | Burden of Illness in Prostate Cancer Patients with a Low-to-Moderate Risk of Progression: A One-Year, Pan-European Observational Study |
| Q34560743 | CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer |
| Q92065389 | Cancer Detection Rates of Systematic and Targeted Prostate Biopsies after Biparametric MRI |
| Q35864027 | Castration-resistant prostate cancer: mechanisms, targets, and treatment. |
| Q28085013 | Cellular Plasticity in Prostate Cancer Bone Metastasis |
| Q39375743 | Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play |
| Q104616284 | Clinical, Histopathological, and Prognostic Characteristics of Patients with Prostate Cancer in Lubumbashi, Democratic Republic of Congo |
| Q38755459 | Comments on the extraperitoneal approach for standard laparoscopic radical prostatectomy: what is gained and what is lost |
| Q40029512 | Comparison of transperineal mapping biopsy results with whole-mount radical prostatectomy pathology in patients with localized prostate cancer. |
| Q38808076 | Complications, urinary continence, and oncologic outcomes of laparoscopic radical prostatectomy: single-surgeon experience for the first 100 cases |
| Q38807747 | Contemporary radical prostatectomy |
| Q92242040 | Corrigendum to "Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States" |
| Q42007027 | Cryotherapy for primary treatment of prostate cancer: intermediate term results of a prospective study from a single institution |
| Q35890508 | Current Patterns of Management of Advanced Prostate Cancer in Routine Clinical Practice in Spain |
| Q38042634 | Current challenges in development of differentially expressed and prognostic prostate cancer biomarkers |
| Q42005789 | DWI of Prostate Cancer: Optimal b-Value in Clinical Practice. |
| Q89884979 | Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population |
| Q39105066 | Development and External Validation of a Nomogram Predicting the Probability of Significant Gleason Sum Upgrading among Japanese Patients with Localized Prostate Cancer. |
| Q38112122 | Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer |
| Q37650468 | Does Statin or ASA Affect Survival When Prostate Cancer Is Treated with External Beam Radiation Therapy? |
| Q42009301 | Dose-escalated hypofractionated intensity-modulated radiotherapy in high-risk carcinoma of the prostate: outcome and late toxicity |
| Q39101579 | Effect of zoledronic Acid on bone mineral density in men with prostate cancer receiving gonadotropin-releasing hormone analog |
| Q48189307 | Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis. |
| Q21284745 | Emerging molecularly targeted therapies in castration refractory prostate cancer |
| Q42268071 | Emerging putative biomarkers: the role of alpha 2 and 6 integrins in susceptibility, treatment, and prognosis. |
| Q35608923 | Environment as a potential key determinant of the continued increase of prostate cancer incidence in martinique |
| Q94925097 | Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program |
| Q35608952 | Epigenetics in prostate cancer |
| Q43077367 | Erratum to "prostate cancer in South Africa: pathology based national cancer registry data (1986-2006) and mortality rates (1997-2009)". |
| Q59072903 | Erratum to “Primary Zonal High Intensity Focused Ultrasound for Prostate Cancer: Results of a Prospective Phase IIa Feasibility Study” |
| Q39196789 | Evaluating the Impact of PSA as a Selection Criteria for Nerve Sparing Radical Prostatectomy in a Screened Cohort |
| Q30791827 | Evidence suggesting that obesity prevention measures may improve prostate cancer outcomes using data from a prospective randomized trial |
| Q26744606 | Evolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing Controversies |
| Q41847322 | Expression of neutral endopeptidase, endothelin-1, and nuclear factor kappa B in prostate cancer: interrelations and associations with prostate-specific antigen recurrence after radical prostatectomy |
| Q38807901 | Factors implicated in radiation therapy failure and radiosensitization of prostate cancer |
| Q39101615 | First danish single-institution experience with radical prostatectomy: biochemical outcome in 1200 consecutive patients. |
| Q26765503 | Fortifying the Treatment of Prostate Cancer with Physical Activity |
| Q38807889 | Frequency of positive surgical margin at prostatectomy and its effect on patient outcome |
| Q38160862 | Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers |
| Q36640906 | Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent |
| Q36469104 | Growth and Progression of TRAMP Prostate Tumors in Relationship to Diet and Obesity |
| Q41136849 | HMGB1: A Promising Therapeutic Target for Prostate Cancer |
| Q35687541 | Histone deacetylase inhibitors restore cell surface expression of the coxsackie adenovirus receptor and enhance CMV promoter activity in castration-resistant prostate cancer cells |
| Q64071634 | How Accurately Can Prostate Gland Imaging Measure the Prostate Gland Volume? Results of a Systematic Review |
| Q26750584 | Hydrogen Sulfide Signaling Axis as a Target for Prostate Cancer Therapeutics |
| Q42233149 | Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry |
| Q36711751 | Hypofractionated external-beam radiotherapy for prostate cancer |
| Q42045691 | Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer |
| Q94570855 | Impact and Outcomes of Pretreatment Total Serum Testosterone on Localized Prostate Cancer Patients |
| Q64227252 | Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States |
| Q92279331 | Incidence of Skeletal-Related Events in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US |
| Q42195623 | Incidentally found prostate cancer and influence on overall survival after radical cystoprostatectomy |
| Q39585024 | Increased aPKC Expression Correlates with Prostatic Adenocarcinoma Gleason Score and Tumor Stage in the Japanese Population |
| Q37539188 | Influence of In Utero Maternal and Neonate Factors on Cord Blood Leukocyte Telomere Length: Clues to the Racial Disparity in Prostate Cancer? |
| Q91533415 | Inhibition of Prostate Cancer Cells by 4,5-Dicaffeoylquinic Acid through Cell Cycle Arrest |
| Q36415432 | Intake of grains and dietary fiber and prostate cancer aggressiveness by race |
| Q64083847 | Interactions between Germline and Somatic Mutated Genes in Aggressive Prostate Cancer |
| Q98502978 | Interleukin-10 Induces Expression of Neuroendocrine Markers and PDL1 in Prostate Cancer Cells |
| Q92221674 | Knowledge, Perceived Risk and Utilization of Prostate Cancer Screening Services among Men in Dar Es Salaam, Tanzania |
| Q38747414 | Laparoscopic sentinel lymph node biopsy for prostate cancer: the relevance of locations outside the extended dissection area. |
| Q55083046 | Local Treatment of Metastatic Prostate Cancer: What is the Evidence So Far? |
| Q90780243 | Long-Term Follow-Up after Prostatectomy for Prostate Cancer and the Need for Active Monitoring |
| Q35936700 | Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer |
| Q41639827 | Long-term efficacy and tolerability of abdominal once-yearly histrelin acetate subcutaneous implants in patients with advanced prostate cancer. |
| Q35991148 | Markers of field cancerization: proposed clinical applications in prostate biopsies |
| Q35433102 | Metabolic complications and increased cardiovascular risks as a result of androgen deprivation therapy in men with prostate cancer |
| Q35225370 | Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis. |
| Q39103527 | Minimally invasive ablative therapies for definitive treatment of localized prostate cancer in the primary setting |
| Q58693513 | Mouse models of prostate cancer |
| Q38257845 | Natural history of untreated prostate specific antigen radiorecurrent prostate cancer in men with favorable prognostic indicators |
| Q38745981 | New insights into the androgen-targeted therapies and epigenetic therapies in prostate cancer. |
| Q33594364 | Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer |
| Q35549975 | Oncologic outcomes of asian men with clinically localized prostate cancer after extraperitoneal laparoscopic radical prostatectomy: a single-institution experience |
| Q42713856 | Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology |
| Q38756156 | Pathology update for urologists |
| Q39373854 | Pelvic Radiotherapy versus Radical Prostatectomy with Limited Lymph Node Sampling for High-Grade Prostate Adenocarcinoma |
| Q36495701 | Personalized management in low-risk prostate cancer: the role of biomarkers. |
| Q37719087 | Pharmacokinetic and Biodistribution Assessment of a Near Infrared-Labeled PSMA-Specific Small Molecule in Tumor-Bearing Mice |
| Q35157412 | Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients. |
| Q35863963 | Postoperative radiotherapy after radical prostatectomy: indications and open questions |
| Q40541815 | Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies |
| Q90780230 | Prevalence of Anxiety and Depression in Prostate Cancer Patients and Their Spouses: An Unaddressed Reality |
| Q92006466 | Prevalence of the Ser217Leu Variant of the ELAC2 Gene and Its Association with Prostate Cancer in Population of the Littoral Region of Cameroon |
| Q37577271 | Primary Zonal High Intensity Focused Ultrasound for Prostate Cancer: Results of a Prospective Phase IIa Feasibility Study |
| Q94925104 | Prognostic Factors for Overall Survival of Patients with Prostate Cancer in Kyadondo County, Uganda |
| Q37960019 | Prognostic factors for the development of biochemical recurrence after radical prostatectomy |
| Q38757041 | Proliferative tumor doubling times of prostatic carcinoma |
| Q38807805 | Pros and cons of focal therapy for localised prostate cancer |
| Q28073470 | Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy |
| Q26749961 | Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine |
| Q30832800 | Prostate cancer in South Africa: pathology based national cancer registry data (1986-2006) and mortality rates (1997-2009) |
| Q35433274 | Prostate cancer incidence and mortality in barbados, west indies |
| Q35433317 | Prostate cancer incidence rates in Africa |
| Q35564143 | Prostate cancer patients' refusal of cancer-directed surgery: a statewide analysis. |
| Q35375078 | Prostate cancer severity associations with neighborhood deprivation |
| Q38729662 | Prostate intrafraction translation margins for real-time monitoring and correction strategies |
| Q38808255 | Pseudolumen size and perimeter in prostate cancer: correlation with patient outcome |
| Q41844846 | Quantifying the ki-67 heterogeneity profile in prostate cancer |
| Q35615137 | Racial disparities in prostate cancer incidence, biochemical recurrence, and mortality |
| Q35368777 | Racial/Ethnic patterns in prostate cancer outcomes in an active surveillance cohort |
| Q36449643 | Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007 |
| Q35549871 | Rectourinary fistula after radical prostatectomy: review of the literature for incidence, etiology, and management |
| Q36369319 | Relationship of dietary intake of omega-3 and omega-6 Fatty acids with risk of prostate cancer development: a meta-analysis of prospective studies and review of literature |
| Q37960020 | Review of small cell carcinomas of the prostate |
| Q30586073 | Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 Trial |
| Q35549909 | Robot-assisted laparoscopic radical prostatectomy in the morbidly obese patient |
| Q41824197 | Robotic Prostatectomy Has a Superior Outcome in Larger Prostates and PSA Density Is a Strong Predictor of Biochemical Recurrence |
| Q38239683 | Robotic radical prostatectomy in patients with previous prostate surgery and radiotherapy. |
| Q38833812 | Role of heparan sulfate 2-o-sulfotransferase in prostate cancer cell proliferation, invasion, and growth factor signaling |
| Q33942673 | Role of p73 Dinucleotide Polymorphism in Prostate Cancer and p73 Protein Isoform Balance. |
| Q37960021 | Role of signaling transduction pathways in development of castration-resistant prostate cancer |
| Q39863303 | Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy. |
| Q33873770 | Single high intensity focused ultrasound session as a whole gland primary treatment for clinically localized prostate cancer: 10-year outcomes |
| Q39139686 | Skip Regulates TGF- β 1-Induced Extracellular Matrix Degrading Proteases Expression in Human PC-3 Prostate Cancer Cells. |
| Q99249609 | Somatic Mitochondrial DNA Point Mutations Used as Biomarkers to Demonstrate Genomic Heterogeneity in Primary Prostate Cancer |
| Q38808009 | Specimen orientation by marking the peripheral end: (potential) clinical advantages in prostate biopsy |
| Q38730156 | Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells |
| Q89868528 | Synthetic Apparent Diffusion Coefficient for High b-Value Diffusion-Weighted MRI in Prostate |
| Q26746913 | Systematic Review of Focal Prostate Brachytherapy and the Future Implementation of Image-Guided Prostate HDR Brachytherapy Using MR-Ultrasound Fusion |
| Q26772255 | Systematic Review of the Relationship between Acute and Late Gastrointestinal Toxicity after Radiotherapy for Prostate Cancer |
| Q38808131 | Systematic analysis of transrectal prostate biopsies using an ink method and specific histopathologic protocol: a prospective study |
| Q91642438 | The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour's TMPRSS2-ERG Fusion Status |
| Q64097169 | The Biopsychosocial Burden of Prostate Biopsy at the Time of Its Indication, Procedure, and Pathological Report |
| Q35390159 | The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy. |
| Q64964104 | The Prognostic PDE4D7 Score in a Diagnostic Biopsy Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes. |
| Q91943954 | The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player? |
| Q26747230 | The Single-Knot Running Vesicourethral Anastomosis after Minimally Invasive Prostatectomy: Review of the Technique and Its Modifications, Tips, and Pitfalls |
| Q35947920 | The current role of androgen deprivation in patients undergoing dose-escalated external beam radiation therapy for clinically localized prostate cancer |
| Q36546399 | The role of targeted focal therapy in the management of low-risk prostate cancer: update on current challenges |
| Q37418939 | The role of vascular endothelial growth factor in metastatic prostate cancer to the skeleton |
| Q36016027 | Thioredoxin 1 in Prostate Tissue Is Associated with Gleason Score, Erythrocyte Antioxidant Enzyme Activity, and Dietary Antioxidants |
| Q39193963 | Triptorelin in the Relief of Lower Urinary Tract Symptoms in Advanced Prostate Cancer Patients: The RESULT Study |
| Q94570850 | Understanding and Improving 18F-Fluciclovine PET/CT Reports: A Guide for Physicians Treating Patients with Biochemical Recurrence of Prostate Cancer |
| Q40531588 | Urodynamic evaluation after high-intensity focused ultrasound for patients with prostate cancer |
| Q36682716 | Urologic characteristics and sexual behaviors associated with prostate cancer in an african-Caribbean population in barbados, west indies |
| Q37957896 | Using molecular markers to help predict who will fail after radical prostatectomy |
| Q37413302 | Variation in HNF1B and Obesity May Influence Prostate Cancer Risk in African American Men: A Pilot Study. |
| Q36488630 | Vitamin d levels in subjects with prostate cancer compared to age-matched controls |
| Q35549861 | Younger age is an independent predictor for poor survival in patients with signet ring prostate carcinoma |
Search more.